Ignite Creation Date:
2025-12-24 @ 1:58 PM
Ignite Modification Date:
2025-12-28 @ 2:30 AM
Study NCT ID:
NCT00101595
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2005-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
2007-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-12
Completion Date Type:
ACTUAL
First Submit Date:
2005-01-12
First Submit QC Date:
None
Study First Post Date:
2005-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2010-02-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-07
Last Update Post Date:
2011-04-14
Last Update Post Date Type:
ESTIMATED